Treatment progress of multiple myeloma:reports from the 57th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2016.02.007
- VernacularTitle:多发性骨髓瘤治疗进展：第57届美国血液学会年会报道
- Author:
Hua BAI
;
Xiaoyan QU
;
Jianyong LI
;
Lijuan CHEN
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Diagnostic criteria;
Neoplasm,residual;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2016;25(2):86-88
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myeloma is one of common hematological malignancies. The 57th American Society of Hematology annual meeting has mainly reported the several crucial topics, which covered recent changes to the diagnostic criteria, risk stratification, maintenance therapy, novel combination approaches and chimeric antigen receptors T cells therapy for myeloma in the era of novel agents, and the significances and detection methods of minimal residual disease for myeloma.
